Kymanox Growth Continues, Signs Former Biogen Director

Wednesday, March 15, 2017 General News J E 4
Ash Patel Joins Kymanox as New Senior Director of Client Services

RESEARCH TRIANGLE PARK, N.C., March 15, 2017 /PRNewswire/ -- Mr. Patel joins Kymanox as an accomplished Operations Director with more than 20 years of experience in Supply Chain, Quality and Manufacturing Operations, Engineering, Capital Projects, Validation, and IT/Automation. He has General Management experience in multi-national biotech companies, such as Biogen and Diosynth Biotechnologies, with a strong record of compliance and value creation. Mr. Patel brings his highly developed communication and leadership skills to help Kymanox clients who are facing a variety of mission-critical challenges.  Also valuable is his international experience that encompassed expansion in Europe, Asia Pacific, and South America with successful implementation of relevant EU and US regulatory requirements.

Mr. Patel earned a degree in Electrical Engineering from the University of Sunderland in England, and is a Master of Business Administration (MBA) from Copenhagen Business School in Denmark. He maintains professional certifications in Quality Auditing (ASQ-CQA), Supply Chain (CSCP), and Quality Management / Organizational Excellence (ASQ-CMQ/OE). 

Mr. Patel states, "I am very excited to be part of this family. The offerings we provide to Biotech, Pharmaceutical, Medical Device, and Sterile Pharmacy organizations is expansive and inclusive of many disciplines. We are providing world-class service unmatched in quality and net value. I look forward to building on the strong foundations and relationships already here." 

"Ash is a strategic addition to the Kymanox team," CEO and Founder Stephen M. Perry remarked. "His new role ensures our continuing ability to understand the complex problems facing our clients who are bringing modern medicines to patients in need around the world."

About Kymanox 

Established in 2004, Kymanox provides technical and compliance solutions for regulated medicine manufacturing. Clients with important commercialization initiatives are served globally in the Life Science areas of Biotechnology, Pharmaceuticals, and Medical Devices.  Leveraging its experienced team and intellectual assets, a broad range of technical services and products are supplied with turnkey project delivery. The Kymanox mission is to improve the human condition by helping make modern medicine manufacturing better, faster, and more affordable.

Kymanox also owns and maintains the following:,,, and Visit to learn more. 

The company headquarters are in the Research Triangle Park (RTP) in Durham, North Carolina with multiple branch offices in the USA. 

Media Contact Laura Penn (Text/Mobile: +1 919-536-9821, Email:

To view the original version on PR Newswire, visit:

SOURCE Kymanox



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Animal Vaccines Market Expected to Reach $9,159 Mi...
Medicom Health Named "100 Best Companies to Work F...